PDB35 LOWER TREATMENT COSTS WITH INSULIN GLARGINE COMPARED TO INSULIN DETEMIR IN TYPE-2 DIABETES PATIENTS ON BASAL-BOLUS THERAPY UNDER REAL WORLD CONDITIONS IN GERMANY
Oct 1, 2009, 00:00 AM
10.1016/S1098-3015(10)75013-0
https://www.valueinhealthjournal.com/article/S1098-3015(10)75013-0/fulltext
Section Title :
Section Order :
938
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)75013-0&doi=10.1016/S1098-3015(10)75013-0